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Bullet Points:  
 
• We have used a simple “ultra-slow flow” microfluidic device to differentiate a 
single population of mouse embryonic stem cells into neuron-like cells and 
Schwann cell-like cells, using one of three different neuron-inducing agents and 
Neuregulin, a Schwann cell inducing agent.   
 
• The agents used to induce the neuronal phenotype were nerve growth factor 
(NGF), ciliary neurotrophic factor (CNTF) or macrophage migration inhibitory 
factor (MIF), the neurotrophic cytokine that is critical for inner ear development in 
vertebrates. Use of different agents resulted in differences in neuronal properties 
and influenced the observed early steps in myelination. 
 
• We tested the influence of MIF on directional neurite outgrowth from neuron-like 
cells to the Schwann cell-like cells by inhibiting MIF biochemically or by blocking 
its effects with a function-blocking monoclonal antibody.   Statistically significant 
reductions in directed neurite outgrowth were observed under all conditions, but 
especially if MIF was used as the neural inducing agent.    
 
• We then  “coated” cochlear implants with alginate hydrogel layers containing the 
MIF-producing Schwann cell-like cells.  Primary mouse statoacoustic ganglion 
neurons, spiral ganglion neurons and MIF-induced neuron-like cells exhibited 
directed outgrowth in vitro to two types of cochlear implants: implants meant for 
human implantation and implants used in animal (e.g. gerbil) studies. No directed 
outgrowth from any of the “neuronal” subtypes was seen toward a “bare” or 
hydrogel coated cochlear implant or implants coated with undifferentiated 
embryonic stem cells.  
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• Macrophage migration inhibitory factor (MIF)-induced neuron-like-cells exhibited 
directed neurite outgrowth to a wild type mouse Organ of Corti explant in culture 
but not towards a MIF-knock out organ of Corti explant.   
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Background: To send meaningful information to the brain, an inner ear cochlear implant 
(CI) must become closely coupled to as large and healthy a population of remaining 
Spiral Ganglion Neurons (SGN) as possible. Inner ear gangliogenesis depends on 
macrophage migration inhibitory factor (MIF), a directionally attractant neurotrophic 
cytokine made by both Schwann and supporting cells (Bank et al., 2012). MIF-induced 
mouse embryonic stem cell (mESC)-derived “neurons” could potentially substitute for 
lost or damaged SGN. mESC-derived “Schwann cells” produce MIF as do all Schwann 
cells (Huang et al., 2002; Roth et al., 2007, 2008) and could attract SGN to “ cell 
coated” implant.  
 
Results: Neuron- and Schwann cell-like cells were produced from a common population 
of mESC in an ultra-slow flow microfluidic device. As the populations interacted; 
“neurons” grew over the “Schwann cell” lawn and early events in myelination were 
documente . Blocking MIF on the Schwann cell side greatly reduced directional neurite 
outgrowth. MIF-expressing “Schwann cells” were used to “coat” a CI: mouse SGN and 
MIF-induced “neurons” grew directionally to the CI and to a wild type but not MIF-knock 
out Organ of Corti explant.  
 
Conclusions: Two novel stem cell-based approaches for treating the problem of 
sensorineural hearing loss are described. 
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Development of new stem cell-based therapeutic approaches is bringing the era of 
regenerative medicine into more immediate focus. For example, a current area of 
intense interest to neuroscientists and bioengineers is the potential replacement of lost 
or diseased central and peripheral neurons and/or peripheral nervous system Schwann 
cells with biologically engineered stem cells. Ideally, stem cells would be capable of 
taking on the mature properties of both neuronal and Schwann cell types and could also 
participate in the critical crosstalk that leads to myelination of the neurons by Schwann 
cells. 
The inner ear’s spiral ganglion’s myelinated bipolar neurons (SGN) provide the 
conduit for sensory messages from peripheral sensory receptors of mechanosensory 
hair cells to the central neurons in auditory brain stem nuclei. When the hair cells in the 
Organ of Corti are lost or incapacitated, due to injury, ageing or loss of function resulting 
from genetic disorders, spiral ganglion neurons lose their peripheral targets and can 
progressively degenerate, so that the remaining neurons are less capable of functional 
interaction with either the remaining sensory Organ of Corti hair cells or with a cochlear 
implant/prosthesis (Pfingst et al., 2015, review). Although spiral ganglion neuron loss in 
humans is less pronounced than in animal models of hair cell loss or Knock out mouse 
models of hair cell loss (Bermingham-McDonogh and Rubel, 2003; Bodmer, 2008; 
Breuskin et al., 2008), it appears that even if spiral ganglion neurons remain as long as 
40 years post onset of deafness, their functionality can be impaired (Sato et al., 2006; 
Wise et al., 2010),(Jiang et al., 2006).  
In order to interact productively with a cochlear implant, the surviving spiral ganglion 
neurons must be healthy and sufficiently well-distributed along the cochlea to cover the 
range of frequency distribution required to deliver the necessary information for speech 
discrimination (Parkins, 1985). Although conductive hearing loss can be remediated by 
using hearing aids, middle ear implants and bone anchored hearing aids, a direct 
stimulation of the auditory nerve is required when sensorineural hearing loss is severe. 
Such stimulation can be achieved by implanting cochlear prostheses/implants in the 
scala tympani of the cochlea.  However, in the future, direct auditory brain stem 
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implants may well become the standard therapeutic approach (reviewed in Merkus et al, 
2014).  
Some very promising studies of hearing restoration have recently been done in 
mammalian animal models.  Endogenous Supporting cells of the inner ear have been 
shown to differentiate and replace hair cell function (e.g. Mellado Lagarde et al., 2014; 
Wan et al., 2013; Monzack and Cunningham review, 2014).  Human inner ear stem 
cells transplanted into deafened animal models also restored hearing function (Chen, 
Jongkamonwiwat et al., 2012).  
Strategies for prolonging survival or regenerating spiral ganglion neurons, many 
focused on earlier-identified inner ear neurotrophins as inducing agents (Roehm and 
Hansen, 2005; Ramekers et al., 2012) have been a focus of research for many years.  
To restore hearing function and prolong survival of existing spiral ganglion neurons, 
some researchers have developed paradigms in which a single neurotrophin or a 
cocktail of neurotrophins was administered to deafened animals using mini osmotic 
pumps or via cochlear implants coated with various gels/hydrogels that can slowly 
release such neurotrophins (Winter et al., 2007; Jun et al., 2008; Winter et al., 2008; 
Jhaveri et al., 2009). However, such treatment options have not yet progressed to 
clinical or even pre-clinical trials in patients with hearing loss (Miller et al., 2002; 
Pettingill et al., 2007a, b; O'Leary et al., 2009b; Pfingst et al., 2015).  
To improve the performance of cochlear implants, a variety of different strategies to 
improve hearing perception are being tested; among these are: 1. Advanced 
engineering of cochlear implant devices, which can communicate well with the brain 
stem (for a review see Pfingst et al., 2015), 2. Cell replacement therapies, involving 
various types of stem cells to augment or substitute for lost or malfunctioning neurons 
(Corrales et al, 2006; Coleman et al., 2007: Reyes et al., 2008; Chen, Jongkamonwiwat 
et al., 2012) 3. Re-growing spiral ganglion neuronal processes to improve connections 
with the implant and concomitantly to reduce the distance between them (Altschuler et 
al., 1999); 4. “Classical” neurotrophin-releasing Schwann cells used to ‘coat’ cochlear 
implants have been shown to enhance neurite contacts with the devices (O'Leary et al., 
2009).  
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The research described in this report focuses on two stem cell-based strategies to 
address sensorineural hearing loss: Replacement of damaged or lost spiral ganglion 
neurons and neurotrophic factor-producing cells that could enhance the attractive 
properties of a cochlear implant. We used a very-slow-differential-flow microfluidic 
device (Park et al., 2009), to differentiate a common population of embryonic stem 
cells into two different types of cells—neuron-like cells and Schwann cell-like cells, 
using differential flow to deliver inducing agents for neurons and Schwann cells 
simultaneously in two streams of fluid, which, although side by side move at different 
flow rates.  
When macrophage migration inhibitory factor (MIF)—and not nerve growth factor 
(NGF) or ciliary neurotrophic factor (CNTF)-- is the neuron-inducing agent, we show that 
the neuron-like cells bear some significant resemblance to statoacoustic ganglion or 
spiral ganglion neurons of the inner ear. NGF and CNTF also induce neuronal 
phenotypes; we have shown in other studies that NGF produces dorsal root ganglion-
like neurons and CNTF induced motor neuron-like neurons (Roth et al., 2007, 2008; 
Bank et al., 2012).   We have previously shown that MIF is the inner ear’s first 
developmentally important neurotrophin (Holmes et al., 2011; Shen et al., 2011; Shen et 
al., 2012; Bank et al., 2012, cited in Faculty of 1000) and that receptors for MIF remain 
on spiral ganglion neurons into adulthood (Bank et al, 2012).  These earlier studies 
were done in conventional tissue culture devices/dishes.  
In this study, the MIF-induced neuron-like cells produced on the “neuronal” 
differentiation side of the slow-flow microfluidic devices were characterized for 
electrophysiological functional maturation by patch clamping and for transporters, 
neurotransmitters and appropriate ion channel expression by immunocytochemistry and 
RTqPCR.  The MIF-induced neuron-like cells’ properties were compared to the neuron-
like cells induced with Nerve Growth Factor (NGF) or Ciliary Neurotrophic Factor 
(CNTF) as we had done previously in our conventional tissue culture studies (Roth et 
al., 2007, 2008; Bank et al., 2012).  The neuron-like cells’ maturation is enhanced by 
exposure to docosahexaenoic acid (DHA), which is capable of enhancing both 
electrophysiological functional maturation (Uauy et al., 2001; Khedr et al., 2004) and 
myelination in the microfluidic device (Fig. 4).   
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Neuregulin (Gambarotta et al., 2013) was used to induce Schwann cell-like cells as 
in our previous studies (Roth et al., 2007, 2008) in the other fluid stream of the device. 
Our laboratory made the first embryonic stem cell-derived Schwann cells almost a 
decade ago (Roth et al., 2007).  We demonstrated previously that these engineered 
Schwann cells have all the properties of myelinating Schwann cells (Roth et al., 2007), 
acquire Schwann cell-like properties in the expected order during maturation and that 
they produce MIF as do all vertebrate Schwann cells (Huang et al., 2002). 
Such stem cell-derived neuron-like and Schwann cell-like cells could be used 
independently or together to provide therapeutic approaches to alleviate a variety of 
neurological disorders, including multiple sclerosis (Taupin, 2011; Zhang et al., 2011) 
spinal cord injury (Paino et al., 1994; Goodman et al., 2007; Zhang et al., 
2007;Boomkamp et al., 2012); Parkinsonism (Mena and Garcia de Yebenes, 2008); 
peripheral nerve regeneration (Namqung et al., 2015) and, most importantly for these 
studies, sensorineural hearing loss/ deafness (Pettingill et al., 2008).  Replacement 
of the sensory hair cell population from stem cells endogenous to the inner ear is also 
under investigation (Li et al., 2003a,b; Liu et al, 2014) although not in these studies.  
It has been difficult to study the stages of neuron-Schwann cell interactions that 
result in myelination in conventional tissue cultures of primary peripheral system 
neurons and Schwann cells (Gingras et al., 2008; Heinen et al., 2008; Callizot et al., 
2011; Jarjour et al., 2012) for several reasons: 1) the inability to distinguish living 
primary neurons from Schwann cells in conventional cell co-cultures during the 
differentiation and interaction process (Paivalainen et al., 2008), unless one population 
or the other is tagged with a live cell label; 2) the difficulty in obtaining immature cultures 
of both primary neurons and Schwann cells in order to observe and document the key 
EARLY steps in their interactions that lead to myelination and 3) sufficiently specific 
stage-specific markers of myelination progress, as our earlier studies documented (Roth 
et al., 2007, 2008).  
Tissue engineered co-culture systems have been somewhat successful in identifying 
key molecular steps and markers in studies of myelination (Hsu and Ni, 2009; Liazoghli 
et al., 2012). A number of such co-culture systems have involved variously derived stem 
cells (Yang et al., 2008: Wei et al., 2010; Xiong et al., 2012; Yang et al., 2012) mostly to 
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provide the “neuronal” component. However, none of these engineered stem cell based 
systems has been sufficient to observe the continuum of cell-cell interactions that result 
in early events in myelination.  
The very slow-flow devices used in these studies allows us to study 
neuronal/Schwann cell interactions that result in onset of myelination during the course 
of the experiment, which can be carried out for up to 6 weeks. An osmotic pump is 
essential to achieving sufficiently slow flow with low shear that does not cause cell 
detachment and that allows us to culture cells in devices with nutrient replenishment 
and eliminate wastes for up to 6 weeks.  
The device was designed to generate overlapping gradients of one of the 
neurotrophic factors (MIF, NGF or CNTF; Bank et al., 2012) as well as Schwann cell-
inducing factors (Neuregulin; Roth et al., 2007) from two different inlets (see cartoon in 
Fig. 1). By stably maintaining flow over a 3-6 week period, we were able to correlate cell 
differentiation and neuronal outgrowth to computed concentrations of the different 
factors and to document many aspects of the interactions between the two cell types in 
the device—particularly the very early events in myelination. The microfluidic device 
allows us to study the cell-cell interactions between the “neurons” and the “Schwann 
cells” with time-lapse digital cinematography and also permits molecular, 
immunohistological and electrophysiological analyses of the cells in the device itself.  
The role of MIF produced by the “Schwann cells” in promoting directional outgrowth 
of processes from the “neurons” towards the Schwann cell side of the device was tested 
in two ways.  After the embryonic stem cells had differentiated into “Schwann cells” or 
“neurons” we blocked MIF production on the Schwann cell side of the device with the 
biochemical MIF inhibitor, 4-iodo-6-phenylpyrimidine (4-IPP; Specs, Delft, Netherlands) 
at 0.1 µM 4-IPP for 7 days, as we have done previously (Shen et al., 2012).  In another 
set of experiments, we blocked MIF downstream pathways with a monoclonal antibody 
to MIF using conditions we previously established for studies of both mouse and chick 
cultured primary neurons and stem cell derived neurons (Bank et al., 2012).   Blocking 
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MIF resulted in a significant reduction in directional neurite outgrowth towards the 
“Schwann cell” lawn in the microfluidic devices (Fig. 2), just as we previously 
demonstrated in conventional tissue culture experiments (Bank et al., 2012).  
Once we had convincing data confirming our earlier studies that MIF appears to be 
involved in directional neurite outgrowth either through its direct effects (see fig. 1 in 
Bank et al., 2012) or through its production by an mESC-derived “Schwann cell” lawn 
(see fig. 5B in Roth et al., 2007), we used the MIF-producing mouse embryonic stem 
cell-derived Schwann cells, encapsulated in sodium algenate hydrogels, to coat two 
types of cochlear implants: the multi-electrode type commonly used in human patients 
and the simple ball type used in animal studies.  
Directional outgrowth of neurites from primary mouse statoacoustic ganglion (which 
is the embryonic precursor of both the spiral ganglion and vestibular ganglion in the 
vertebrates that develop both SG and VG) and spiral ganglion explants extending 
neurites toward the devices was observed by time-lapse cinematography.  Contacts 
with the implants were visualized by immunocytochemistry using specific markers.  
MIF-induced neuron-like cells were also co-cultured with mouse Organ of Corti 
explants and directional outgrowth of neurites towards the target was documented 
towards wild type but not the MIF-knock out Organ of Corti explants.  We had already 
demonstrated that this could be done with primary neurons in conventional tissue 
culture (Bank et al., 2012).  
This study could eventually benefit two types of patients—1) those with low spiral 
ganglion neuron counts who are not good candidates for cochlear implant therapy, for 
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whom a replacement population of stem cell derived neuron-like exogenous cells could 
enhance functional contacts with their own native Organ of Corti sensory hair cells and 
2) patients for whom cochlear implants coated with MIF-producing Schwann cell-like 
cells could markedly improve directional outgrowth of their remaining spiral ganglion 
neurites to the cochlear implant.  
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Concomitant differentiation of mouse embryonic stem cells (mESC) into neuron-
like cells and Schwann cell-like cells in a slow flow microfluidic device 
We differentiated mouse embryonic stem cells into both neuron-like cells and 
Schwann cell-like cells in the same microfluidic device to study cell differentiation and 
maturation (neuronal or Schwann cell) as well as any cell-cell interactions between the 
Schwann cells and the neurites emerging from the neuron-like cells; e.g. those that 
might result in evidence of myelination upon contact with the Schwann cell-like cells.  
The microfluidic system was designed to establish a gradient flow to nourish the 
stem cells with nutrients and growth factors or neurotrophic cytokines in order to 
facilitate the differentiation of two different cell populations from a single undifferentiated 
stem cell population seeded on the device.  Figure 1c is a bright-field image of 
undifferentiated mouse embryonic stem cells (ESC; Doetschman et al., 1985) seeded 
over the entire surface area of the device after coating the device with sterile porcine gel 
(see Experimental Procedures).  A cartoon of the device, with the  “neuron” side 
depicted in red and the “Schwann cell” side depicted in blue is seen in Fig. 1b. Then, 
using differential flow, Schwann cell-like cells were induced to form on the right half of 
the device (blue outflow source seen in the cartoon in Figs. 1b and 1d) using 
concentrations of Neuregulin that we had previously determined produced myelinating 
Schwann c lls (Roth, Ramamurthy et al., 2007, 2008).   
One of 3 different inducing agents was used to produce the neuron-like cells in 
the left (red Fig. 1b) half of the device: NGF, CNTF or MIF at concentrations we had 
previously optimized (Roth et al., 2007, 2008; Bank et al., 2012; see Experimental 
Methods).  The “neuron”-inducing agent was delivered form the reservoir indicated in 
red in the cartoon in Figs.1b and 1d. DHA enhancement was also tested in the 
microfluidic devices in some cases and it was delivered through the same portal. DHA 
enhancement had proven to be very effective in our previous studies, even at the lowest 
concentration we tested (Bank et al., 2012).  Three to 8 duplicate devices for each 
inducing agent or condition were prepared in parallel, incubated, fixed, labelled (e.g. 
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with antibodies to Neurofilament or TUJ1), photographed and analyzed for each set of 
conditions using MetaMorph© software.  
After one week in the microfluidic devices, we saw both morphological and 
molecular evidence of neuronal differentiation on the “neuronal” side of the device under 
all neuron-inducing conditions at the concentrations tested (see experimental methods), 
including DHA alone.  Neurofilament-positive cell bodies with extensive processes were 
documented photographically and analyzed by MetaMorph© or NIH ImageJ software.  
By contrast, little if any neuronal differentiation was seen at 1 week in the presence of 
F12 medium alone (control) (Fig. 2), as we had also previously documented (Roth, 
Ramamurthy et al., 2007, 2008; Bank et al., 2012).   
After 2-3 weeks, we observed that more than 75% of the mES cells exhibited 
neuronal processes in response to NGF, CNTF or MIF as well as to any of these 
inducing agents enhanced with DHA.  However, because the “neuron-like” cells were 
clumped together and the processes were found in fascicular bundles (e.g. Bank et al., 
2012, Fig. 2), it was often difficult to determine the actual numbers of neuron-like cell 
bodies in the clumps or how many processes were present in the fascicles. 
Fasciculation was enhanced markedly by the addition of DHA.  
 
Directional Neurite Outgrowth is observed from the Neuron-like cells towards the 
“Schwann cell” sectors in Microfluidic Devices 
 
To determine if there was preferential neurite outgrowth from the neuron-like 
cells toward the Schwann cell-like cells in the microfluidic device (Fig. 1a), we used 
time-lapse videomicrography and end-stage photomicrography to identify immuno-
labelled (neurofilament or TUJ1) cells and processes on the “Schwann cell” side of the 
devices. Photographs of the immuno-labelled cells were analyzed by MetaMorph© or 
NIH ImageJ software.  For these analyses, we virtually sectioned the device into 5 rows 
(I, II, III, IV, V; Figs. 1a and 1b).  Rows II, III and IV were divided into three columns for 
taking the photomicrographs used in these analyses (see the cartoon in Fig. 1b). The 
mouse embryonic stem cells showed concentration-dependent differentiation from the 
channel inlet to the outflow port (depicted in the cartoon in (Fig. 1b) as a round green 
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area at the bottom. ES cells took on neuronal morphologies in areas closest to the left 
inlet (Fig 1a: I, II). The cells that became neuron-like in sectors I, II and any found in III 
extended neurites toward the Schwann-cell like cell lawns (e.g. Fig. 1a Row I right 
image), since Schwann cell-like cells produce MIF, which is both a neurite outgrowth 
and survival factor for many different neuronal subtypes, including those in the inner ear 
(Bank et al., 2012) and eye (Ito et al., 2008). We tested the role of MIF directly in 
additional studies (Fig. 2 below).  The extension of ramifying processes of the neuron-
like cells over the Schwann cell lawn is also typical of the behaviour of primary neurons 
on such engineered Schwann cell lawns (see Roth et al., 2007 fig. 5b). Neurofilament 
positive neuron-like cells that differentiated in Row III (Fig. 1 a: III middle) had minimal 
numbers of neuronal processes; however, the few processes that were present grew 
directionally towards the Schwann cell lawn (blue side of the device Figs.1a,b). Neuron-
like cells in row IV also could be labelled for neurofilament but no processes developed 
in this region (Fig. 1a IV).  There were cells in row IV that were not stained for 
neurofilament (Fig. 1a) but could be stained for myelin basic protein MBP, indicating 
that they were “Schwann cells” (see also Fig. 4) (as in our previous work, Roth et al., 
2008). Cells in region V did not express markers for either Schwann cells or neurons; 
nor was there evidence of myelination, indicating the undifferentiated ES status of these 
cells, many of which still expressed Oct4 (Roth et al., 2007 2008; Bank et al., 2012), a 
marker for undifferentiated stem cells (Pan et al., 2002). The gradient profile created in 
the device, in which the highest concentrations of neuron-inducing and Schwann cell-
inducing media predominated near the inlets facilitates ES cells’ ’differentiation into 
neuron-like cells and Schwann cell-like cells with a much higher expression level of their 
cell type specific protein markers (Fig. 1a I, II, III). Neurites extending over the Schwann 
cell lawn in row I (Fig. 1a I right) also exhibited the most neurite fasciculation compared 
with the other sections of the device. We observed cell differentiation by both time-lapse 
cinematography and end-stage photomicrography.  We measured the total neurite 
outgrowth of the processes using confocal microscopy and light photomicrography, 
analyzed by MetaMorph© software or NIH ImageJ software (Experimental Procedures).  
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MIF production by Schwann cell-like cells appears to play a role in directional 
process outgrowth 
 
When devices were stained with an antibody to Neurofilament and appropriate 
secondary antibodies, little or no directional outgrowth towards the “Schwann cell” side 
of the device was seen under any of the “neuron-inducing” conditions (Fig. 2) if there 
were no cells on the “Schwann cell” side of the device. This was also the case if there 
were undifferentiated mESC (not exposed to Neuregulin) on the “Schwann cell” side. 
However, if Neuregulin had been used to induce a Schwann cell-like phenotype, there 
was a significant directional process outgrowth towards the Schwann cell lawns (Fig. 
2).  Compare the process outgrowth towards the undifferentiated mouse embryonic 
stem cell lawns [mESC] with outgrowth towards mESC induced to become Schwann 
cell like with Neuregulin [ESSC] (Fig. 2).  mES Schwann cell differentiation resulted in 
ramification of “neuron-like” processes over the Schwann cell lawns, no matter which 
neuronal inducing agent was used on the “neuron” side (see also Fig. 5B Roth et al., 
2007).   However, more extensive process outgrowth and more extensive fasciculation 
were seen if the inducing agent was MIF (Fig. 2), and the difference was significant 
(compare the statistics for the various neurotrophic inducing agents included in the 
caption to Fig. 2).  
As we had demonstrated in our previous studies (Roth, Ramamurthy et al., 2007; 
Bank et al., 2012), MIF production by the differentiated Schwann cell like cells induced 
by Neuregulin appears to provide a major impetus for this process extension, whether 
by primary neurons (Fig. 5B, Roth et al., 2007) or stem cell-derived “neurons” (Fig. 2).  
We examined this directly by blocking MIF downstream effects in one of two ways: 1) 
The biochemical MIF inhibitor, 4-iodo-6-phenylpyrimidine (4-IPP; Specs, Delft, 
Netherlands), at a final concentration of 0.1 µM, was used as described previously 
(Shen et al., 2012) or 2) a MIF function-blocking monoclonal antibody, also used as 
described previously (Bank et al., 2012). These MIF blocking strategies were used 
ONLY on the Schwann cell side of the device (seen in Blue in the cartoon in Fig. 1) 
once the both cell types (“neuron-like and “Schwann cell-like”) had phenotypically 
differentiated. Use of either means of inhibiting MIF downstream effects reduced the 
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extent of “neurite” outgrowth over the “Schwann cell” lawns to levels seen when either 
no cells or undifferentiated mESC (no Neuregulin) were plated on the “Schwann cell” 
side of the device.  This difference was particularly significant for the MIF-induced 
“neurons” (Fig. 2; significance calculations below in the caption).   
In summary, for “neurons” induced by DHA alone and by each neurotrophin 
(CNTF, NGF and MIF) the ES SC condition has a significantly higher mean value for 
directional neurite outgrowth than the mESC, ES SC+4iPP, and α-MIF conditions.  This 
is not surprising since all Schwann cells are known to produce MIF (Huang et al., 
2002a,b; Nishio et al., 2002; Bank et al., 2002) as well as another neurotrophic cytokine, 
monocyte chemoattractant protein 1 (Bianchi et al., 2005; Roth et al., 2007, 2008; Bank 
et al., 2012).  Furthermore, vertebrate statoacoustic ganglion neurons, spiral ganglion 
neurons and MIF-induced stem cell derived neurons are known to express MIF 
receptors (Shen et al., 2012; Bank et al., 2012) and to continue to express these 
receptors into adulthood (Bank et al., 2012).  We have shown that MIF is a directional 
neurite outgrowth factor for many neuronal subtypes, particularly those in the inner ear 
(Roth, Ramamurthy et al., 2007).  We have also shown that it is a neuronal survival 
factor (Bank et al., 2012).     
 
Neuron-like cells in the microfluidic devices develop neuronal characteristics as 
assessed by appearance of neuronal markers measured with RTqPCR   
 
Analysis of neuronal differentiation using primer pairs (Table 1) for neuronal 
markers and for undifferentiated ES cells (Oct4 expression; Pan et al., 2002) was done 
by RTqPCR as in our previous studies (Roth et al., 2007; Roth et al., 2008; Bank et al., 
2012).  Oct4 remained at high expression levels under proliferative conditions (no 
neuronal differentiation media added) and was down-regulated under differentiation 
conditions (Fig.3a). Cells treated with cytokines or neurotrophins alone showed a 2-fold 
down-regulation of Oct4 gene expression and cells treated with DHA as well as MIF 
and/or neurotrophins showed a four-fold Oct4 down-regulation when compared with the 
undifferentiated conditions (Fig. 3a). 
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In general, neurotrophins (Flores-Otero et al. 2007; Bank et al., 2012) are 
thought to provide molecular signals that mediate the survival of neurons. In mice, 
ganglion neuron precursors and developing cochlear neurons express the proneural 
gene Ngn-1. NeuroD and neurofilament (Nfil) are upregulated early in inner ear 
development (Flores-Otero et al. 2007; Nayagam et al., 2011; Yang et al., 2011; 
Shibata et al., 2011: Reyes et al., 2008).  In spiral ganglion neurons, three different 
forms of Nfil are expressed sequentially (Nayagam et al., 2011;Yang et al., 2011). In 
these studies, we found Ngn-1 expression was upregulated under all neuronal 
differentiation conditions when compared with cells grown in F12 basal media 
(undifferentiated conditions) (Fig.3b). Expression of NeuroD was upregulated in cells 
treated with MIF alone, with CNTF+DHA, NGF+DHA and MIF+DHA (Fig.3b). A rise in 
NeuroD expression levels suggests that MIF alone without DHA could support the 
differentiation and survival of stem cell-derived-neurons. CNTF, MIF, CNTF+DHA, 
NGF+DHA, MIF+DHA significantly increased NeuroD expression when compared with 
mES cells grown in the F12 basal medium.  
Neurofilament (Nfil) expression was upregulated significantly under all the 
differentiation conditions compared with F12 basal medium. Nfil expression was 
upregulated in cells treated with CNTF+DHA, NGF+DHA and MIF+DHA when 
compared with conditions without DHA (Fig.3b). Proneural gene marker upregulation in 
cells treated with MIF alone and MIF+DHA suggests that the cells’ expression profile is 
consistent with what can be expected of expression in statoacoustic ganglion neurons 
(the spiral ganglion neuronal precursors) (Fig. 3b). 
A number of transcription factors (GATA3, Brn3a, Ngn1, NeuroD, islet1) as well 
as receptors for neurotrophins (TrkB and TrkC) have been defined as mature markers 
for differentiating auditory and vestibular neurons (Nayagam et al., 2011; Shibata et al., 
2011; Yang et al., 2011). Peripherin is also expressed concomitantly with axonal growth 
during development in the inner ear, and its synthesis appears necessary for axonal 
regeneration in the adult (Nayagam et al., 2011; Shibata et al., 2011; Yang et al., 2011). 
TrkB, TrkC and Prphn were significantly upregulated under conditions of DHA 
supplementation of either of the two neurotrophins or MIF (Nayagam et al., 2011; 
Shibata et al., 2011; Yang et al., 2011).  Upregulation of these “mature” neuronal 
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markers and some selected auditory system neuronal markers are seen in Figs. 3c and 
3d.  
Differentiated neuron-like cells were stained for VgluT1 (a marker for spiral ganglion 
neurons of the inner ear), Neurofilament 200 (a neuronal marker) and myelin basic 
protein (MBP), which labels mature, neuron-interactive myelinating Schwann cells (Roth 
et al., 2007, 2008) (Fig. 1, Fig. 3). Differentiation conditions under which cells were 
treated with NGF, CNTF or MIF, either of the neurotrophins+DHA, or MIF+DHA 
exhibited more extensive neurite outgrowth than was seen in the F12 Basal medium. 
Differentiation conditions with neurotrophins or with MIF supplemented with DHA have 
extensive fasciculated bundles of neurites, which were positive for the glutamate 
transporter, VgluT1 and neurofilament (Nfil200kDa). By contrast, few neurites stained 
for both VgluT1 and Nfil200 under conditions in which CNTF, NGF, MIF or DHA alone 
were used as the inducing agents. All the differentiated neuron-like cells in the mid 
region of the device showed healthy neurite outgrowth over the lawn of Schwann cell-
like cells as did cells treated with CNTF+DHA, NGF+DHA and MIF+DHA (see Fig.2 for 
total neurite outgrowth measurements).  
A substantial increase in glutamatergic properties (e.g. increased VgluT staining of 
neurites), robust neurite outgrowth with multiple branches as well as evidence of 
myelination in the device were all found in MIF-induced neuron-like cells. Although 
these properties do not exclusively define spiral ganglion neurons, development of 
these properties indicates that the cells were developing at least some of the properties 
of spiral ganglion neurons. Such criteria would be critical if the “neuronal” population 
were to prove adequate substitutes for lost or diseased spiral ganglion neurons in vivo.  
Evidence of Early Steps in Myelination is seen in the Microfluidic Devices in CNTF 
and MIF-derived “neurons”: 
If NGF was used as the inducing agent, little evidence of myelination was seen 
during the time course of these experiments (up to 30 days), even in the presence of 
DHA (NGF+DHA: Fig 4 or the presence of Schwann cell-like cells. However, neuron-like 
cells induced by CNTF showed evidence of myelination with and without DHA in the 
presence of Schwann cell-like cells. When neuron-like cells were induced with the 
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neurotrophic cytokine, MIF, the presence of DHA greatly enhanced evidence of 
myelination in the presence of the Schwann cell-like cells (Fig. 4).  
The process of myelination is extremely difficult to follow at the cellular level in its 
entirely in (approximately) real time in vivo, without sacrificing large numbers of animals.  
Even in vitro, using primary cell cultures of neurons and Schwann cells, the process is 
difficult to observe (Callizot et al, 2011).  However, in the microfluidic device, we have 
created a microenvironment in which the cells can be differentiated concomitantly into 
the two lineages. We can now begin to study the interaction between the two cell types 
by time lapse video and by stage-specific immuno-labelling (Roth et al., 2007) as they 
mature and mutually influence the other population’s development, as happens in vivo 
(Salzer, 2012, 2015; Glenn and Talbot, 2013; Kidd et al., 2013).  Schwann cell myelin 
production requires the influence of neurons capable of carrying on the complex 
sequence of required cell-cell interactions and molecular cross talk (Bodhireddy et al., 
1994; Roth et al., 2007; Salzer, 2012, 2015).  We had previously found evidence of 
early steps in myelination in interactions between primary inner ear statoacoustic 
ganglion neurons and a “Schwann cell” lawn produced by inducing the Schwann cell 
phenotype in embryonic stem cells (Roth et al., 2008).  
Importantly, the slow flow feature of our device, which closely approximates 
interstitial flow with respect to diffusion strength, is physiological for neuronal cells. 
Neurons usually develop in and remain separated from high flow rate environments 
(blood flow or even lymphatic flow in the body), which at least for the CNS, where 
oligodendrocytes and not Schwann cells myelinate neurons, is maintained by the blood-
brain barrier. It is important to note that even in such flow-free environments, neurons 
still require a replenished nutrient supply and waste clearing by minimal convective flow, 
which is also achieved in our slow flow device. Stability of the flow in the channel is 
guaranteed since the operation of the flow is based simply on osmosis, a very stable 
phenomenon. The overall pattern of the two differentiated cell types in the device 
suggests that the neuron-like cells grown with the Schwann cell-like cells exhibited 
directional outgrowth towards the Schwann cell-like target cells (e.g. Fig. 1a Row 1 
right).  This observation  recapitulates our earlier finding that neurites from primary 
ganglionic explants similarly ramify over such a stem cell-derived Schwann cell lawn 
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(Roth et al., 2007). There is ample evidence of the early stages of myelination (Fig. 4) 
as these differentiating “neurons” and “Schwann cells” interact.  
 
Properties of neuron-like cells differentiated by MIF or MIF+DHA could lend 
themselves to replacement strategies for inner ear neurons 
We used whole-cell patch clamp electrophysiological recordings to determine 
whether the neuron-like cells derived from mES cells induced with MIF had excitable 
properties that showed voltage gated inward and outward currents.  This would be the 
minimum requirement for action potentials and therefore render these cells capable of 
encoding frequency information from a cochlear implant electrode and conveying it to 
the central nervous system (CNS). After 3 weeks, an excitable population of neuron-like 
cells was identified in the 80% of cells that had taken on a neuronal morphology.  The 
population with measurable excitable properties was approximately 25% of the cells 
with a neuronal morphology. By contrast, if the mESC were exposed to the F12 basal 
medium without any differentiation factors, no such properties could be documented.  
To explore the underlying cause of these electrophysiological changes, we 
investigated the voltage-dependent properties of Na+ and K+ currents using whole-cell 
voltage-clamp electrophysiology. We detected voltage dependent inward and outward 
current with long active response times in the MIF/DHA exposed “neurons” (Fig. 5c) 
whereas the cells in F12 media alone (basal medium) showed no neuronal morphology 
and no active responses or any inward or outward currents. Electrophysiological 
recordings were also made in the NGF+DHA condition. However, no inward or outward 
currents were found. We also labelled the MIF and/or DHA-induced neuron-like cells for 
ion channel protein expression with antibodies for sodium ion channel SP19 and 
potassium ion channel Kv3.1 on the same cell preparation (double labeling).  SP19 was 
distributed all over the somas and along the neurites, as well intra-cellularly (potentially 
nuclear staining); Kv3.1 was also expressed in the cell body and along the processes, 
although the staining was less well defined (data not shown).  This finding does, 
however, agree with our RTqPCR data (see Table 1).  
 
Coating of SC cells on Cochlear implants using hydrogel layering   
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We were sufficiently encouraged by the preliminary analyses of MIF-neuron-like 
cells that showed these cells had features that could potentially serve in the place of 
spiral ganglion neurons, to proceed to “coating” CIs with MIF-producing Schwann cell-
like cells.  We then followed the interaction of the MIF-induced neuron-like cells with 
these “coated” implants in vitro. Earlier work by Shepherd’s group (Pettingill et al., 2007) 
had demonstrated that CIs could be coated with neurotrophin-expressing Schwann cells 
that would attract SGN.   
Two different types of platinum iridium electrodes (kindly provided by Dr. Bryan 
Pfingst, Dept. Otolaryngology Head and Neck Surgery, University of Michigan) were 
“coated” with Schwann cell-like cells or undifferentiated mESC using 1% sodium 
alginate hydrogel as a scaffold; both types of coated CIs were grown in culture for two 
weeks (Fig. 6). The cultures were supplemented with fresh media every week.  Control 
electrodes were either uncoated, coated in hydrogel layers without cell inclusions or 
coated with undifferentiated mESC in the hydrogel layers.  Fig. 6a is a photograph of a 
cochlear implant of the type used in human patients, coated with Schwann cell-like cells 
in the hydrogel layers (5 layers are readily discerned in this photograph).  Figs. 6b 
through 6d are photographs of the type of cochlear implant electrode used in animal 
studies. All are photographs of the same electrode.  Five layers of hydrogel containing 
Schwann cell-like cells are seen in Fig. 5b.  Fig. 5c, is a close up phase contrast 
photograph of the electrode ball head.  The encapsulated cells were stained for live and 
dead cells with ethidium bromide and calcein (LIVE/DEAD® Cell Viability Assays, 
Invitrogen, CA). Large numbers of healthy cells (green) and very few dead cells 
(orange) were found in the hydrogel layers coated with the Schwann cell-like cells (Fig. 
6c) or undifferentiated ES cells (control; not shown) at 6 weeks in culture.  
 
Extension of primary mouse statoacoustic ganglion or spiral ganglion neurites 
towards the Schwann cell-like cell-coated cochlear implant but not a bare 
cochlear implant was seen by time lapse digital microscopy: 
 
Cochlear implant electrodes of the ball type seen in Fig. 5b-d were then co-
cultured with a) intact primary embryonic mouse statoacoustic ganglia or intact post-
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natal spiral ganglia or b) neurons dissociated from these ganglia to determine whether 
the neurites would demonstrate directional outgrowth towards the cell coated cochlear 
implants.  We monitored the entire interaction by time-lapse digital videography on a 
specially designed microscope with a gas-supplied (5% CO2) tissue culture incubator on 
the stage over 5-14 days. Neurite migration and directional outgrowth trajectories were 
also photographed every 24 hrs after addition of the cochlear implants to cultures of the 
primary ganglia.  
We first tested whether primary statoacoustic ganglion neurons exhibited 
directed neurite outgrowth toward cochlear implants coated with hydrogels that 
contained Schwann cell-like cells.  A cocultured  SAG explant and the  Schwann cell 
coated cochlear implant or a SAG explant and a bare implant were placed 1 cm apart in 
the tissue culture dish and a video camera was programmed to capture images at 
different locations over the dish at 20 min intervals over 5-14 days. We then analyzed 
the images to observe any evidence of neurite extension or directional outgrowth from 
the ganglion towards the implant. No directed outgrowth was seen towards bare 
cochlear implants under any conditions.  By contrast, after 2 days, 87%+ 4% of the 
processes took the direction towards the Schwann cell-like cell-coated cochlear implant, 
even if during the first 2 days some outgrowth was random and non-directional. We also 
observed that the explant itself in some cases split in half and some of the neurons 
themselves (with and without underlying glial cells) migrated in the cochlear implant’s 
direction.   
The long-term co-culture (2 wks) of Schwann cell-like cell-coated cochlear 
implant and statoacoustic ganglia showed directional outgrowth of neurites and 
extensive contact of neuronal processes on the Schwann cell-like cell-coated cochlear 
implant from both statoacoustic ganglion neurons explants and dissociated cells. No 
neurite outgrowth whatever was seen towards “bare” cochlear implants, those coated 
with hydrogel but not cells or implants coated with hydrogels containing undifferentiated 
mESC. Although some processes were seen emerging from the ganglia under the three 
“control” conditions (bare implant, hydrogel but not cell coated implant or 
undifferentiated mESC in the hydrogels), the neurite processes were short, emerged 
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randomly from all sides of the explants and showed no directionality or appreciable 
extension even after 2 weeks.  
In marked contrast, from day 3 onwards, neuronal processes emerging from the 
statoacoustic ganglia were observed to turn in the direction of the Schwann cell-like cell-
coated cochlear implants and to migrate towards them. The emerging neurites and  
some migrating cell bodies could be positively stained for neurofilament marker protein 
throughout the experiment.  
By two weeks, the statoacoustic ganglion neurites had reached the cochlear 
implant (Fig. 7) and had penetrated the hydrogel layers containing Schwann cell-like 
cells in the hydrogel layers. Fig. 7 a and b are fluorescence micrograph (Fig. 7a) and 
phase contrast micrograph (Fig. 7b) of the same part of the coated electrode surface. In 
Fig. 7a Neurofilament 150kDa (Nfil) (red) was used to label the neuronal processes and 
a few cell bodies.  In this double-labelled photograph, the blue staining (DAPI) is 
associated with the Schwann cell-like cell nuclei.  These are more clearly visible in Fig. 
7c, where the DAPI stained nuclei are heavily concentrated close to the electrode head 
and seen to belong to the Schwann cell like cells (compare Fig. 7c with 7a).  A few 
neuronal c ll bodies that stained with DAPI are seen in the area above the concentrated 
Schwann cell layers (Fig. 7c).     
 
Directional outgrowth of neurites from SGN was seen towards a variety of 
targets: 
Spiral ganglia isolated from the 6-day old postnatal mouse cochlea were also 
cocultured with bare cochlear implants, or with hydrogel coated cochlear implants 
containing Schwann cell-like cells or undifferentiated mESC.  We used the same 
culturing techniques, cinematographic and photographic techniques to observe neurite 
extension and document any directional outgrowth both under the light microscope and 
by time-lapse live cell imaging.  At the experiments end, the cultures were stained for 
neurofilament and DAPI.  Again, we found that directional neurite outgrowth was only 
seen towards the Schwann cell-like cell coated-cochlear implants. Initially, as with the 
primary statoacoustic ganglia, at least some outgrowth of neurites was observed 3600 
around the cluster of spiral ganglion neuronal cell bodies.  After the 3rd day of co-
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culture, the majority (91+6 %) of the neurites showed directional outgrowth towards the 
Schwann cell-like cell-coated cochlear implant and processes reached the implant by 8-
9 days in culture. Neurite outgrowth from spiral ganglion neurons in the presence of a 
bare cochlear implant or one coated with undifferentiated mES cells showed little 
extension and no directional outgrowth at all even after 2 weeks in co-culture (data not 
shown).  
These migration and directional outgrowth studies demonstrate that a Schwann 
cell-like cell-encapsulated cochlear implant could potentially deliver directional 
molecular cues to attract neurites of an endogenous adult spiral ganglion.  Importantly, 
we had previously demonstrated that receptors for MIF remain on spiral ganglion 
neurons into adulthood (Bank et al., 2012).  
 
Neuron- like mESC-derived cells’ directional outgrowth towards targets:   
The MIF-induced/DHA enhanced neuron-like cells were assessed after a week of 
co-culture for directional migration and directional outgrowth towards: a) Organ of Corti 
explants derived from 6 day old postnatal mouse cochleae (wild type or derived from a 
MIF knock out mouse) as described in our previous studies (Bank et al., 2012); b) A 
bare cochlear implant; c) A cochlear implant coated with Schwann cell-like cells; d) A 
cochlear implant coated with undifferentiated mouse embryonic stem cells (mESC); e) A 
hydrogel coated cochlear implant without cells. The neuron-like cells exhibited few 
emerging processes and no directional neurite outgrowth toward the bare cochlear 
implant, the hydrogel-coated (no encapsulated cells) cochlear implant or the mESC-
coated cochlear implant.  In contrast neuron-like cells co-cultured with the Schwann 
cell-like cell-cochlear implant showed long processes, rapid migration and directional 
outgrowth towards the cochlear implant (71+11% of the processes were oriented 
towards the cochlear implant).  However, these processes became so fasciculated that 
measurements of total “oriented” processes became difficult over time.  
MIF-induced neuron-like cells co-cultured with the 6-day old postnatal wild type 
mouse Organ of Corti explants showed clusters of neurites with growth cones and 
multiple branches growing towards the wild type Organ of Corti (Fig. 8b). Compare this 
outgrowth with the robust neurite outgrowth emerging from a wild type primary spiral 
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ganglion neurons towards the wild-type Organ of Corti explant seen in Fig. 8a.  Little 
outgrowth, random emergence of processes and no directional outgrowth of neurites 
was seen if the Organ of Corti explant came from a MIF knock out mouse.  These data 
recapitulate our finding with primary neurons and Organ of Corti explants. Neither 
statoacoustic ganglion neurites nor spiral ganglion neurites emerged towards a MIF 
knock out Organ of Corti explant (Bank et al., 2012).  These studies indicate that the 
MIF/DHA-induced neuron-like cells derived after 3 weeks exposure to the neurotrophic 
cytokine MIF and DHA can migrate towards appropriate targets in vitro. Functionality is 
being tested electrophysiologically. However, directional outgrowth and 
electrophysiological function remain to be thoroughly tested when such electrodes are 
implanted in vivo in animal models.  
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Concomitant differentiation of neuron-like cells and Schwann cell-like cells in a 
microfluidic device  
Two novel stem cell-based therapeutic strategies for producing cell populations that 
could be used to alleviate sensorineural hearing loss have been assessed in these 
studies. We have differentiated a common population of mouse embryonic stem cells 
(mESC) (Doetschman et al., 1985; Roth et al., 2007, 2008, Bank et al., 2012) into 
neuron-like and Schwann cell-like cells simultaneously in a slow flow microfluidic 
device.   
These studies were based on earlier work in which we used conventional tissue 
culture for such differentiation studies.  Our lab had produced the first embryonic stem 
cell based model of both the myelinating and non-myelinating Schwann cell in 2007 
(Roth et al., 2007, 2008).   We also induced mouse embryonic stem cells to take on 
neuronal phenotypes with different characteristics depending on which neurotrophin 
was used as the inducing agent (NGF, CNTF: Roth et al., 2007, 2008; MIF: Bank et al., 
2012).  In these studies, we also used Neuregulin (as in Roth et al., 2007, 2008) to 
induce the mESC to become Schwann cell-like on the “Schwann cell” side of the 
microfluidic device.  
Although both NGF and CNTF served as the “control” neuron-inducing agents in the 
microfluidic studies, we used MIF as the inducing neurotrophic cytokine in most of the 
studies detailed here both in the microfluidic model and in additional tissue culture 
based experiments.  This was because we had previously demonstrated that MIF is the 
first neurotrophin expressed in the developing inner ear (Holmes et al, 2011; Shen et 
al., 2012; Bank et al., 2012), that it is responsible for the earliest steps in both 
neurogenesis and directional neurite outgrowth and that it is a neuronal survival factor 
(Bank et al., 2012). We had also previously demonstrated that inner ear spiral ganglion 
neurons retain the appropriate receptors for MIF into adulthood (Bank et al., 2012).  The 
neuron-like cells induced by MIF in either conventional tissue culture dishes (Bank et al. 
2012) or, as we show here in microfluidic devices, can bear significant resemblance to 
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inner ear spiral ganglion neurons (Bank et al., 2012).  The use of DHA enhances the 
maturation of such “neurons” in conventional tissue culture and in the microfluidic 
devices.  
In the microfluidic devices, concomitant neuronal cell-type specific differentiation 
was seen and documented in morphological, molecular and electrophysiological assays 
in the devices themselves. These devices spare both cells and reagents and are labour-
saving because the reservoirs supply a continuously delivered source of medium and 
factors (see the cartoons in Figs. 1c, d).  Neuron-like cells extended processes over the 
Schwann cell lawns (Fig. 1a) and interactions between the ‘neurons’ and ‘Schwann 
cells’ resulted in the early steps of myelination (Fig. 4).  We had previously 
demonstrated such directional outgrowth and early steps in myelination in conventional 
tissue culture experiments (Roth et al., 2008).  The proximity of the two differentiating 
cell populations in the device is as critical for development of mature properties in both 
populations as it is in vivo. Without intimate contact with neurons, Schwann cells do not 
develop myelin components; nor, of course do they myelinate any cells in their 
environment except neurons. The role of MIF in myelination is under study in a number 
of systems.  Disrupting pathways known to be downstream of MIF, such as Jab1, are 
known to cause dysmyenination (Porrello et al., 2011).  Such pathways can be easily 
studied in these microfluidic devices and in model organisms such as the zebrafish 
(Weber et al., in preparation) as in more comprehensive studies of the events in 
myelination (Han et al., 2013; Glenn and Talbot, 2013).  
The extremely slow flow maintained in the microfluidic device over 3 weeks allows 
for the accumulation of autocrine and paracrine factors that would ordinarily be washed 
through the device if the flow rate were accelerated (Park et al., 2009). This slow flow 
also allows for interactions between the two differentiating cell populations that emerge 
from the common population of ES cells—neuron-like and Schwann cell like cells.  The 
two cell populations differentiate “side by side” and interactions between them can be 
documented.  
We addressed the role of MIF in the observed directional outgrowth of neuron-like 
cells to the “Schwann cell” side of the device by inhibiting MIF’s down stream effects in 
one of two ways: use of the biochemical MIF inhibitor 4-iPP as we had done previously 
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(Shen et al., 2012) or by using a function-blocking antibody to MIF, again as we had 
done in previous studies (Bank et al., 2012).  We found that blocking MIF by either of 
these means on the Schwann cell side of the device once the embryonic stem cells had 
differentiated into Schwann cell-like cells, we could significantly reduce directional 
neurite outgrowth over the Schwann cell lawn, no matter which neurotrophin was used 
to induce the neuron-like phenotype (Fig. 2).  However, the greatest effect was seen if 
MIF was the inducing agent or if MIF were enhanced with DHA.  Note that blocking MIF 
did not totally eliminate directed neurite outgrowth over the Schwann cell lawn.  This is 
because Schwann cells are known to produce another neurotrophic cytokine, monocyte 
chemoattractant protein 1 (MCP1) which also is produced by sensory hair cells of the 
inner ear (Bank et al., 2012) and which we have shown to affect both directional neurite 
outgrowth from inner ear neurons and their survival (Bianchi et al., 2005; Bank et al., 
2012).  The effect of blocking MCP1 was not tested in these experiments.    
 
Meeting a long-term objective: Producing a stem-cell-derived neuronal population 
that phenotypically has some resemblance to that of the inner ear’s spiral 
ganglion neuron.  
 
One objective of these studies is to produce a stem cell-derived population of 
neuron-like cells that could potentially replace lost or damaged spiral ganglion neurons 
in human patients, potentially using a patient’s own induced pluripotent stem cells 
(Oshima et al., 2010) as a source of such neurons that could alleviate sensorineural 
hearing loss.   
Researchers have previously attempted to develop glutamatergic neurons from ES 
cells by transient expression of neurogenin 1 and supplementation with BDNF and 
GDNF.  These neurons were found to have some characteristics of spiral ganglion 
neurons, including electrophysiological functionality (Reyes et al., 2008). The ‘neurons’ 
were also implanted in an animal model (Reyes et al., 2008), although no functional 
improvement of a malfunctioning auditory system was demonstrated.  
More promising later studies from the Rivolta group demonstrated that some 
significant improvement in hearing function could be achieved in a deafened gerbil 
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model (Chen, Jongkamonwiwat et al., 2012) when human embryonic inner ear stem 
cells were implanted into the deafened animals.  However, the derivation of neurons 
from human inner ear stem cells required a complex multi-step many week in vitro 
protocol for neuronal differentiation before implanting the cells. By contrast to these 
complex differentiation protocols, the ES to neuron conversion described here and in 
our previous studies requires only a single step with recombinant MIF (Bank et al. 
2012).  It is worth emphasizing that MIF is the inner ear’s earliest expressed 
neurotrophin and that this neurotrophic cytokine controls gangliogenesis in the 
vertebrate inner ear (Shen et al., 2012; Bank et al., 2012).  Its use in eliciting a neuronal 
population is preferable to the use of other nerve growth factors (NGF, CNTF) or 
cytokines, largely because we have also demonstrated that ADULT SGN retain 
receptors for MIF (Bank et al., 2012).  
 
Therapeutic Potential: A neuronal replacement strategy 
 
Neuron-like cells derived from MIF and DHA-induced ES cells could potentially be 
used in the future to replace lost or damaged sensory neurons of the spiral ganglion in 
adults. However, if this paradigm is to be successful, several important hurdles will have 
to be met, some of which would be incurred in optimizing the neuronal cell implant 
procedure itself and some of which involve meeting critical criteria for monitoring 
functional connections of the “neuronal” population to the Organ of Corti if the implant 
were to be successful.  
First, the cells must have cellular, molecular and electrophysiological properties 
sufficiently similar to the cells they replace to be functionally “competent” in situ. Second 
any implanted substitute “neuronal” population would have to remain viable and capable 
of extending “neurites” in vivo, towards a source of molecular cues that could provide 
directional signals and sustain their survival.  
MIF is exactly such a neuronal directional outgrowth and survival factor (Holmes et 
al., 2011; Shen et al., 2012; Bank et al., 2012).   MIF is produced in the native Organ of 
Corti by the supporting cells that underlie each sensory hair cell and by the Schwann 
cells of the inner ear (Bank et al., 2012). The neurite outgrowth documented in these 
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microfluidic studies demonstrates that the neuron-like cells also respond to 
chemoattractant-producing (MIF-producing) Schwann cells in the microfluidic devices. 
Either a function-blocking antibody to MIF (Bank et al., 2012) or the biochemical MIF 
inhibitor, 4-iodo-6-phenylpyrimidine (4-IPP, Shen et al., 2012) can prevent directed 
outgrowth of these neuron-like cells towards the Schwann cell target cells, 
demonstrating that MIF production by the Schwann cell like cells is a key feature of the 
neuron-like cells’ directed outgrowth.  A MIF-producing Schwann cell like cell-coated 
cochlear implant could also provide such cues and is discussed later in this section.  
The number of surviving “neuron-like” cells has to be sufficient to provide functionally 
viable “neurons” over however many days are required for their neuronal processes to 
reach the target tissue (surviving hair cells in the Organ of Corti presumably via the MIF-
producing supporting cells that cup each sensory hair cell) or the cochlear implant. 
If the target tissue is the native Organ of Corti, the implant site would have to be 
optimized and two additional critical criteria would have to be met: the implanted cells 
cannot form a tumor or dedifferentiate and proliferate, even if the cell bolus that 
eventually forms is benign.  
In the future, in order to prevent tumor formation in the inner ear, once the spiral 
ganglion neuronal processes have contacted the cochlear implant, a cell suicide 
cassette could be triggered to eliminate the Schwann cell-like cells (e.g. Li, Zhang et al., 
2012), the cell debris of which would presumably be removed by macrophages.  Slow 
release gels (e.g. Inaoka et al., 2009) that release recombinant MIF could also be used 
to coat the cochlear implants, but even with slow release, the supply of MIF in these 
gels would eventually be exhausted.  It is not known how long it would be necessary to 
supply MIF to ensure that a maximum number of spiral ganglion neuronal processes 
reach the implant and form functional contacts.  Using a stem cell-based source of MIF 
could provide the cytokine for a much longer time. The possibility of infection must also 
be minimized.  
How far have we come towards realizing these criteria? MIF and DHA are capable of 
inducing some properties in the mESC-derived neurons that are similar to those of 
spiral ganglion neurons under the conditions of the experiment. These include: 1) 
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VgluT1 (a marker for spiral ganglion neurons of the inner ear) transporter expression 
and protein, which was documented in MIF and DHA induced neuron-like cells.  
However, the transporter is also expressed to the same extent in nerve growth 
factor- (NGF-) or ciliary neurotrophic factor- (CNTF-) induced mESC-derived neurons, 
each of which could also provide a viable source of ‘neurons’. 2) Electrophysiological 
excitability and the possibility of action potentials: Ion channel expression was assessed 
by RTqPCR and at the protein level by immunocytochemistry.  The neuron-like cells’ 
physiological properties were evaluated by whole cell patch clamping. We were 
encouraged by the preliminary electrophysiological experiments showing that MIF+DHA 
could induce a neuronal population with promising electrophysiological properties. No 
inward or outward currents were found when electrophysiological recordings were made 
from the neuron-like cells induced by either NGF or NGF+DHA. 
The cells also expressed ion channels (sodium and potassium channels) that are 
expected for spiral ganglion neurons (Greenwood et al., 2007; Xie et al., 2007), but 
sodium channel protein expression was better defined in the immunohistochemistry 
labeling experiments than potassium ion channel expression on the neurites.  
These experiments demonstrate that these neuron-like cells express some 
functionally mature properties in common with spiral ganglion neurons under in vitro 
conditions. We have not yet documented action potentials under any of these 
conditions; such recordings will be attempted in the future.  
Functionally mature neuron-like mESC-derived cells were experimentally tested for 
directional neurite outgrowth when cocultured with a cochlear implant or primary 
explanted Organ of Corti targets under in vitro conditions. They exhibited directional 
outgrowth towards both the Schwann cell-like coated cochlear implant and wild type but 
not the MIF knock out mouse Organ of Corti explants in culture. Therefore, neuron-like 
cells derived from mESC using MIF and DHA could potentially be implanted as a stem 
cell-based therapy in patients with low spiral ganglion counts who are not presently 
candidates for cochlear implant therapy. 
Potential of ESC-derived Schwann cell-like cells for alleviating sensorineural 
hearing loss 
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The second embryonic stem cell based therapeutic approach described in these 
studies is the production of mESC-derived Schwann cell-like cells. These cells are 
potentially capable of continuous production of molecular cues, including MIF and 
MCP1, that could improve the number of connections between any remaining spiral 
ganglion neurons and a Schwann cell-like cell-coated cochlear implant.  
In these studies, Schwann cell-like cell-coated cochlear implants in vitro were 
studied for their ability to “attract” neurites from both primary embryonic statoacoustic 
ganglion and the mature spiral ganglion. Eventually, such a strategy might be employed 
to enhance the functionality of a cochlear implant. If successful, this could lead to 
improved hearing or better speech perception in patients experiencing hearing loss.  
Schwann cells are known to be important for peripheral nerve regeneration 
(Bhatheja and Field, 2006; Gambarotta et al., 2013). These properties depend on their 
state of differentiation (e.g. quiescent, proliferating or mature Schwann cells) (Baehr and 
Bunge, 1989; Kidd et al, 2013; Salzar, 2012, 2015; Grigoryan and Birchmeier, 2015).  
In earlier studies by other investigators, the effects of factors secreted by Schwann 
cells were examined on a quasi-neuronal model composed of PC12 cells, which are, in 
some investigators’ estimations a model for neuronal cells, which were tested for cell 
survival and “neurite” outgrowth (Bampton and Taylor, 2005). In these experiments, 
Schwann cell-conditioned medium was tested on “neurite” outgrowth from PC12 cells 
against a range of isolated factors known to be secreted by Schwann cells. This 
conditioned medium showed clear neuritogenic effects and suggested that Schwann 
cells are likely candidates for promoting neuronal regeneration (Bampton and Taylor, 
2005; see also Wissel et al., 2008).  
Other groups have reported enhanced survival of spiral ganglion neurons in animal 
models of hearing loss by implanting Schwann cells, which were molecularly 
engineered to provide sustained delivery of neurotrophins such as BDNF (Bunge, 1993; 
Girard et al., 2005; Golden et al., 2007; Pettingill et al., 2008). Such an engineered 
population of Schwann cells was used to coat a cochlear implant, with some success in 
attracting spiral ganglion neurons to the implant (Pettingill et al., 2008).   
However, the group attributed the attraction of the spiral ganglion neurons to the 
Schwann cells on the implant to the engineered neurotrophin expression and release by 
Page 33 of 72
John Wiley & Sons, Inc.
Developmental Dynamics










the Schwann cells. While this could indeed be the reason, it is also possible that since 
all Schwann cell express MIF, MIF was either the main source of or contributed to the 
attraction.  
If this cell coated cochlear implant strategy were to be successful, initially after 
cochlear implant was introduced, electrical impedance should be higher due to the 
presence of the hydrogel encapsulated cells, but the biocompatible and biodegradable 
hydrogel might release the cells in the perilymph or area surrounding the cochlear 
implant, which could potentially provide sustained neurotrophin release, which would 
also serve to protect the spiral ganglion neurons. Once the hydrogel has completely 
degraded after releasing all the cells, the cochlear implant’s own electrical stimulation 
would presumably function normally, but this has not been examined either in vitro or in 
a living animal.  
 
Combining stem cell based strategies 
 
Various combinations of these approaches could be used.  Neuron-like (especially 
potentially spiral ganglion-like) embryonic stem cell-derived cells could be implanted into 
an inner ear in which hair cell degeneration has begun but not yet progressed to 
complete loss.  Potential stem cell sources could include a human patient’s own 
induced pluripotent stem cells (iPSC) (Oshima et al., 2010). Alternatively, stem cell-
derived Schwann cell-like cells that are capable of sustained delivery of critical 
supporting factors like MIF could be used to coat a cochlear implant. Recall that all 
Schwann cells, including these engineered Schwann cell-like cells produce MIF (Huang 
et al., 2002, Bank et al., 2012). The research studies outlined here are limited to in vitro 
conditions; in the future this approach can be applied in animal models in in vivo 
studies.   
 
Conclusions 
These studies provide first steps towards producing MIF-induced stem cell 
derived neurons that could resemble spiral ganglion neurons sufficiently to replace lost 
or damaged spiral ganglion neurons. Furthermore, Neuregulin-induced Schwann cell-
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like cells that produce MIF could be used to “coat” a cochlear implant that provides a 
source of MIF to which both immature and mature auditory system neurons respond. 
We had earlier demonstrated that both neuronal subtypes retain MIF receptors (Bank et 
al., 2012). Thus a common population of “stem cells”, which in this report are mouse 
embryonic stem cells, but which in the future could be host derived iPS cells, can be 
induced to form two populations of cells that could provide viable approaches for 
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Culturing mES cells  
Cell lines: The cell line used for these studies was the D3 mES cell line (ATCC-CRL-
1934; Doetschman et al., 1985). 10,000 mESC D3 cells were plated onto 0.1% porcine 
gel-coated (Sigma) 48 well Primaria® plates (Falcon) and cells were differentiated over 
a three-week period, using our previously-reported methods (Roth et al., 2007; 2008). 
Undifferentiated mES cells (controls) were fed basal medium daily, while cells in 
neuronal differentiation media and Schwann cell differentiation medium were fed every 
third day.  
 
Media Preparation: Proliferating/undifferentiated (ES medium): 81% DMEM (Invitrogen, 
Carlsbad, CA, USA) without phenol red, but including 1% L-Glut, 1% Pen/Strep, 1% 
nonessential amino acids (Invitrogen), 15% FBS (Atlanta Biological, Lawrenceville, GA, 
USA), 1% sodium pyruvate (2% stock, Sigma Aldrich, St. Louis, MO, USA), 7 µL/L 
mercaptoethanol (Sigma Aldrich), 1,000 U/mL ESGRO (Chemicon, Temecula, CA, 
USA).  
 
Differentiation of mES cell into Schwann cell-like cells in vitro 
Our previously published methods were used to produce Schwann cell differentiation 
(Roth et al., 2007; 2008). The medium consisted of 500 mL alpha modified MEM 
(GIBCO 41061-029), 6% Day 11 chick embryo extract (prepared in house), 10% Heat 
Inactivated FBS, 58 µL Gentamycin (Invitrogen), 10 µL Neuregulin1 (NRG1) (R&D 
Systems). 
 
Differentiation of mES cell into various neuron-like cell types in vitro 
Neuronal differentiation: 95% F-12 (Invitrogen), 1% Pen/Strep (Invitrogen), 1% N2 
(Invitrogen), 2% B27 (Invitrogen), 2% sodium pyruvate (2% stock), 0.5 µg/L bFGF (R&D 
Systems, Minneapolis, MN, USA), 1 µg/L IL-7, 5 µg/L IGF-1 (Sigma), or for specific 
neuronal cell types: 1 µg/L ciliary neurotrophic factor (CNTF; R&D Systems) for motor 
neuron-like neurons (Roth et al., 2007); 1 µg/L nerve growth factor (NGF; Millipore, 
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Billerica MA, CA) (sensory neuron-like cells; Roth et al., 2007); macrophage migration 
inhibitory factor (MIF) 1 µg/mL (R&D Systems), + 5 µM docosahexaenoic acid (DHA; 
Nu-check Prep Inc., Elysian, MN, USA). DHA supplemented media included: CNTF and 
5 µM DHA, NGF and 5 µM DHA, MIF and 5 µM DHA (Bank et al., 2012).  To block MIF 
release from Schwann cell-like cells, either the biochemical MIF inhibitor, 4-iodo-6-
phenylpyrimidine (4-IPP; Specs, Delft, Netherlands) at 0.1µM (Shen et al., 2012) or the 
MIF function-blocking monoclonal antibody under our previously described conditions 
(Bank et al., 2012) were added to the Schwann cell reservoir. These MIF blocking 
strategies were used ONLY on the Schwann cell side of the device once the cells had 
differentiated.  
 
Assessing directed differentiation of D3 cells into neuron-like cells 
After three weeks of growth, cells were labeled for expression of neurofilament marker 
(NF150) (neuronal differentiation marker). Antibodies (Chemicon, MA) were diluted in 
5% normal goat serum (Chemicon) in 0.1% tween20/phosphate buffered saline (PBS) 
(Sigma). Cells were fixed in 4% paraformaldehyde (Sigma), and treated with primary 
antibody NF150 (R&D systems) at 1:500 dilution followed by secondary antibody Alexa 
Fluor 590 at 1:200 dilution (InVitrogen, CA) and DAPI (1:1000 dilution) stain for the cell 
nucleus. Photomicrographs were taken with a light microscope or using appropriate 
filters on a Leica inverted fluorescence microscope. We repeated each set of 
experimental conditions at least three times in separate experiments. The differentiated 
cells were labeled by our previously reported ICC techniques (Roth et al., 2007) for ion 
channel protein expression with antibodies (Abcam, CA) to sodium channel (SP19) and 
potassium channel (Kv3.1). 
 
Isolation and culture of primary mouse Statoacoustic Ganglia Neuron 
(statoacoustic ganglion) 
Statoacoustic ganglia from Balb/C mouse embryos (E15.5-17.5) were isolated from the 
2 ears as previously described (Germiller et al., 2004; Bank et al., 2012) and rinsed in 
PBS (Bianchi and Raz, 2004; Bank et al. 2012). The whole ganglia were then plated on 
0.1% porcine gel-treated Primaria@ plates or 0.1% porcine gel coated glass cover slips 
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(Roth et al., 2008) with the addition of 0.5ml F12 neuronal basal media (InVitrogen) and 
incubated overnight for attachment at 370C in a cell culture incubator with 5% CO2. 
Under some conditions, the statoacoustic ganglia were dissociated and plated as 
individual neurons as previously described (Bianchi et al., 2005; Bank et al., 2012).  
  
Electrophysiological recordings of mESC-derived neuron-like cells; patch clamp 
whole cell recording  
Whole-cell current- and voltage-clamp recordings were performed on cells selected for 
a bipolar neuron-like morphology with long processes. These recordings were made at 
room temperature using an Axopatch 200B amplifier with a Digidata 1200 or 1322A 
digitizer (Molecular Devices, Sunnyvale, CA). Data were acquired using pCLAMP 9 
software (Molecular Devices). Glass electrodes were pulled from borosilicate capillaries 
(World Precision Instruments, Sarasota, FL) to achieve an electrical resistance of 3-6 M. 
Electrodes were filled with an internal solution containing (in mM): 112 KCl, 2 MgCl2, 
0.1 CaCl2, 11 EGTA, 10 HEPES, 5 Na2+ ATP, and buffered to pH 7.2 with KOH. The 
external solution contained (in mM): 137 NaCl, 5 KCl, 1.7 CaCl2, 1 MgCl2, 10 HEPES, 
16 glucose and buffered to pH 7.2 with NaOH.  
 
Isolation of Organ of Corti and explant culture  
 A modification of the method of Parker et al., (2010) was used to isolate mouse OC as 
previously described (Bank et al., 2012). Day 6 neonatal Balb/C mice were first 
decapitated and the outer skin was removed using a scalpel blade. The skull and the 
brain were bisected to expose the temporal bone and the tissue and the bones 
surrounding the temporal bone were removed. The temporal bone was rinsed in sterile 
PBS and transferred to a new plastic 50 mm dish and the cochlea was removed under a 
surgical microscope. The bony labyrinth was carefully separated and the apex of the 
organ of Corti was exposed to visualize the basal cochlea after the removal of the 
labyrinth. Using fine forceps the base was held and the OC carefully removed and 
unwound. The isolated OC explants were positioned on 1% porcine gel coated Primaria 
(Falcon) plates with 0.5mL F12 basal media and incubated at 5%CO2 in a tissue culture 
incubator overnight.  
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Isolation of primary Spiral Ganglia and Spiral Ganglion Neurons 
Once the OC explant was isolated, the modiolus of the cochlea was cut in half and the 
tissue was minced using a scalpel blade. SGN tissue explants were placed on 0.1% 
porcine gel coated Primaria tissue culture plates with 0.5mL F12 media and incubated 
overnight in order to promote attachment as previously described (Bank et al., 2012).  
 
Simultaneous differentiation of neuron-like cells and Schwann cell-like cells in a 
microfluidic device 
Device Preparation and Maintenance: The microfluidic device itself and all tubes, 
pipette tips (used as reservoirs) and equipment were sterilized by the same autoclaving 
and UV sterilizing procedures used in previous studies (Park et al., 2009). PDMS 
microfluidic chambers were autoclaved and subsequently were oxygen-plasma treated, 
so that the channel was hydrophilic. Assembly and operation of the microfluidic system 
was done in a tissue culture hood under positive pressure to prevent possible 
contamination. To prevent air bubble formation initially, a PBS solution-filled 1000 µL 
pipette-tip was inserted into the outlet port, and by the force of gravity; PBS was allowed 
to flow slowly into the main channel without producing any air bubbles in the channel. 
Air bubble formation at all stages of loading, cell seeding and growth was carefully 
examined microscopically. None of the many devices used in these experiments 
developed air bubbles/locks either initially or during the course of the experiment or the 
ensuing analysis. 
The microfluidic devices were designed according to previous specifications (Fig. 1) 
(Park et al., 2009). Microfluidic chambers and tubing were made hydrophilic and 
sterilized by oxygen plasma and UV treatment, respectively. Devices were pre-filled with 
PBS by inserting a 1000 µL pipette tip into the outlet and allowing PBS to fill the 
chamber by gravity-driven flow. Air bubbles were avoided by maintaining liquid (PBS, 
culture medium) on top of the device, thereby preventing bubble formation due to 
evaporation or due to connection of pipette tips. Devices were coated with 0.1% porcine 
gel for 2 h under UV light before cell seeding. mESchwann cellells were trypsinized and 
seeded into devices at a density of 10,000 cells/mL and allowed to adhere overnight at 
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37 oC and 5% CO2. When the mESC were fully attached, an osmotic pump was 
connected to tubing at the outlet channel and 1 mL pipette tip reservoirs containing 
either neuronal differentiation or Schwann cell differentiation media were inserted into 
the appropriate inlets (Park et al., 2009). Devices, including osmotic pumps and inlet 
and PEG reservoirs, were incubated at 37oC and 5% CO2 over three weeks with the 
PEG and inlet reservoirs being replaced once every 7 days.  
 
Assessment of cell type differentiation and myelination in a microfluidic device 
At various time points during the 3-week period, cells were fixed with 4% PFA and 
labeled with either (a) antibody to neurofilament heavy chain protein (200kDa), a 
general marker for neurons, (b) VgluT1, a putative marker for mature “auditory system-
like” neurons, and (c) myelin basic protein, a marker for Schwann cell myelination 
(Bodhireddy et al., 1994; Roth et al., 2007, 2008; Salzer, 2012, 2015). Fluorescent 
images were taken of 5 sections of the microfluidic device to observe the overall pattern 
of neurite outgrowth from the neuron-like cells derived from the mESC and neurite 
extension over the mESC-derived Schwann cell-like cell lawns in the other side of the 
device as well as any evidence of myelination. 
 
COMSOL simulation 
A COMSOL simulation was performed to correlate simulated concentration profiles of 
soluble factors to the observed growth patterns in the device. Microfluidic device 
geometry was imported into COMSOL Multiphysics 4.2 (COMSOL, Inc.). Fluid density 
and viscosity were set based on previous measurements and laminar flow average 
velocities were set at the two inlets (1.4 µm/s) and outlet (2.8 µm/s) based on volumetric 
flow measurements as described in “Medium viscosity measurement” (Supplemental 
Materials). To ensure a fully developed profile, entrance and exit lengths were set to 
1000 times greater than 0.06ReD, where Re and D are Reynolds number of flow and 
tubing diameter, respectively. A laminar flow solver was used to generate flow profiles, 
which, due to the extremely slow flow allowed diffusive mixing of growth factors and 
cytokines at the interface of the two separate laminar streams. Concentration profiles of 
relevant soluble factors were analyzed by the dilute species transport model. Diffusion 
Page 40 of 72
John Wiley & Sons, Inc.
Developmental Dynamics










coefficients were selected to match previous results for molecules with similar molecular 
weights: 1.5x10-10, 4.25x10-10, and 1.27x10-10 m2/s for MIF (Durand et al., 2009), DHA 
(Culbertson et al., 2002) and NGF( Lawrence et al., 2009) (or CNTF, since molecular 
weights are similar), respectively. A quad mesh system with minimum element size of 
3.1x10-7 and maximum element size of 0.154 mm was generated to fully capture flow 
and concentration profiles within the channel for steady laminar flow. 
 
Neurite measurement 
Either the MetaMorph© “Neurite Outgrowth Measurement” program or NIH 
ImageJ software (downloaded from the internet: https://imagej.nih.gov/ij/) was used to 
measure total neurite outgrowth and length of “neurites” under a variety of conditions 
(Figs. 1 and 2). Briefly, thresholds were adjusted so that intensity levels for fluorescent 
detection were 50% above the background grayscale (MetaMorph® instruction manual 
(Universal imaging corporation, documented: T20029). Settings were then optimized for 
cell body size before calculating the above parameters. 
Even though neurites extended only micrometers in the microfluidic device, 
photographs were taken at magnification of 20x in the Leica inverted microscope. Using 
MetaMorph® or ImageJ software we were able to analyze the photomicrographs at the 
maximum pixel size, representing the neurite measurement in microns in length. The 
mean outgrowth could not be normalized to cell numbers because neurite outgrowth 
extends from clusters of the mES cells that are individually indistinguishable.  
 
Statistical analysis 
For quantification of the MetaMorph and ImageJ data, all the experiments were run at 
the minimum in triplicate (e.g. n=8 for all conditions analyzed in Fig. 2). Differences 
between treatment groups were analyzed using Mann-Whitney U tests performed in 
Matlab.  Single tailed tests were performed using the ranksum function and significance 
levels were computed exactly using the ‘method’ ‘exact’ option.   
 
Coating a cochlear implant with hydrogel-encapsulated Schwann cell-Like cells 
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The Schwann cell-like cells were differentiated from mESC following our previously 
published procedures (Roth et al., 2007) and trypsinized using 0.5% trypsin EDTA. The 
cells were counted and diluted to 10,000 cells/mL and centrifuged at 1000RPM for 5 
min. The cell pellet was resuspended in 1 mL of Schwann cell differentiation media and 
1 mL 2% Sodium alginate (hydrogel) tissue culture grade (Pronovo SLG-100, 
Novomatrix) to bring the hydrogel concentration to 1%. To optimize cell growth in 
alginate gels we had first tested different concentrations of sodium alginate from 0.5 – 
2.0%, which was used for encapsulating the SCs at 10,000 cells/mL. We also tested gel 
polymerization achieved with different concentrations of calcium chloride (50mM – 
300mM). Optimized conditions for “Schwann cell” viability and gel firmness were 
determined to be 1% sodium alginate and 200mM calcium chloride for gel 
polymerization.  
The cells were thoroughly mixed with alginate and placed in an ice bath. The 
cochlear implant was coated with hydrogel in order to support Schwann cell growth by a 
modification of the method of Winter et al. (2007) and each implant was monitored daily 
under a light microscope to determine if Schwann cell growth was limited to the vicinity 
of the electrode. The electrode was initially dipped in an ice-cold 200mM CaCl2 solution, 
followed by dipping in the hydrogel – cell mixture solution. This step was repeated to 
cover hydrogel-cell mixture on the cochlear implant up to 2-3mms up to 5-6 layers of 
coating. Then the whole hydrogel – cell and cochlear implant setup was placed in an 
ice-cold 200mM CaCl2 solution for 10 min. Once polymerization was complete, the 
electrode was placed on a tissue culture plate (35mm Falcon) and the encapsulated SC 
allowed to grow for two days with Schwann cell medium supplementation (Roth et al., 
2007). After we observed that the Schwann cell encapsulation was successful, the 
Schwann cell population was tested for survivability. The encapsulated cells were 
checked for viability using the Live/Dead stain (Invitrogen, CA) following the 
manufacturer’s protocol. The cells were stained for Ethidium homodimer (orange 
indicates dead cells) and Calcein (green for the live cells). The Schwann cell coated 
cochlear implant was then used for co culture studies with primary statoacoustic 
ganglion or spiral ganglion neurons or with mESC-derived “neurons” induced by the 
various inducing agents/cytokine.  
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Cocultures of neuron-like cells- with OC explants, with bare cochlear implant or 
“Schwann cell”-coated cochlear implants 
Neuron-like cells were differentiated from mES cells with MIF on porcine-gel-
coated glass coverslips for 2- 3 weeks; mouse Organ of Corti explants (prepared as 
described) were placed in the same 35mm Falcon Primaria TC plate at a distance of 1 
cm to study directional neurite outgrowth towards the target (OC). The cells were 
cultured and fed with F12 basal media for 5 days and neurite outgrowth was observed 
both by time-lapse digital micrography and, at end stage, by ICC staining for TuJ1 for 
neuron-specific class III beta-tubulin. Interactions between the neuron-like cells and the 
“Schwann cell”-coated cochlear implant were monitored in “real time” by placing the 
mESC-derived Schwann cell-like cell coated cochlear implant or bare cochlear implant 
with the differentiated neuron-like cells for 5 days. Directional outgrowth was observed 
and photomicrographs were taken in time-lapse mode at various locations in the culture 
dish every 20 minutes. ICC at “end stage” was performed by fixing the preparation in 
4%PFA followed by neurofilament marker as primary mouse antibody followed by Tuj1 
primary antibody followed by Alexa Fluor 488-conjugated anti mouse secondary 
antibody (Invitrogen, CA). Photomicrographs were taken using a Leica inverted 
fluorescence microscope.  
 
Coculture of MIF-induced neuron-like cells or spiral ganglia with bare cochlear 
implant, (ES)-cochlear implant and (Schwann cell-coated) cochlear implant 
Spiral ganglion (mouse P3) explants were cultured alone for 2 days to promote 
strong attachment to the 0.1% porcine gel-coated plate and then a bare cochlear 
implant or the “Schwann cell”-encapsulated cochlear implant was placed 1 cm away 
from the SG explant. Neurite outgrowth and neurite contact with (Schwann cell) 
cochlear implant or bare cochlear implant were monitored for 5 days and 
photomicrographs were taken at 24 hr intervals using a light microscope. Schwann cell 
(cochlear implant) and spiral ganglion neuron interactions and neurite outgrowth was 
also monitored in live time lapse imaging for 2-4 days post positioning of the ganglion 
explant using a live cell imaging station -Delta vision microscope in the Microscopy and 
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Image Analysis Laboratory of the Cell and Developmental Biology Department. The 
camera was assigned (by computer) to visit different locations repeatedly around the 
plate. The camera was programmed to revolve around the explant and capture time-
lapse images at 20 min intervals. The actual setup of the experiment is shown in Fig. 6.  
 
RTqPCR Assessment of putative SGN marker expression 
 The expression of a variety of SGN-“specific” markers was performed by RTqPCR 
using our previously published methods (Germiller et al., 2004; Bank et al., 2012 and 
modification of methods in Chen et al., 2011), using the primer pairs specified in those 
publications.  
Total RNA was extracted from: a) whole statoacoustic ganglion; b) whole spiral 
ganglia; c) mESC-derived neuronal cultures (+ DHA as described above) at roughly 3 
day intervals over a 30 day period; or d) from co-cultures of mESC-derived “neurons” 
grown on mESC-derived SC lawns (as in Roth et al., 2008). Total RNA was extracted 
using an RNeasy mini kit (Qiagen), reverse-transcribed with Superscript II RNase H-
minus reverse transcriptase (Invitrogen), and amplified using SYBR Green- based PCR 
(Applied Biosystems). Controls included DNase I treatment during RNA isolation) and 
reverse transcriptase-minus and non-template controls during PCR). The sequences of 
the PCR products was confirmed in the University of Michigan’s DNA Sequencing Core.  
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Figure 1. The mouse embryonic stem cells (mESC) seeded on the device differentiated 
into both neuron-like and Schwann cell-like cells.. (a) Photomigrographs of the areas of 
the device depicted as boxes in the cartoon in (b) were taken after the whole device 
was stained for neurofilament 150 kDa – neurites (green); Dapi-nucleus (blue); Myelin 
Basic Protein – evidence of Schwann cell myelination (red). After 3 weeks, the top three 
rows (I, II, III) show significant neuronal differentiation as well as directional outgrowth of 
neurites (green) towards the “Schwann cell” sectors (those on the right).  In the bottom 
two rows (those with the most media intermixing and least preserved gradients), the 
cells apparently did not differentiate into any specific lineage (IV and V). The white 
arrows in (a) indicate the directional outgrowth of neurites. (c) Undifferentiated mES 
cells in the microfluidic device. (d) A cartoon of the microfluidic device. The gradient flow 
illustration (b) and microfluidic chip channel dimensions depicted in (d) are adapted from 
(Park et al., 2009). 
 
Figure 2. Neurite measurements of the neuron-like cells differentiated with different 
neurotrophic factors with and without DHA in the microfluidic device. The “neurites” of 
neuron-like cells cocultured with Schwann cell-like cells in the microfluidic device grew 
directionally towards and over the “Schwann cell” lawn.  Total process lengths were 
measured using MetaMorph® or ImageJ software for this directional outgrowth; 8 
experiments using a minimum of 10 photographed fields of view in each were used.  
mESC = undifferentiated mouse embryonic (D3) stem cells on the “Schwann cell” side 
of the device. ESSC = Embryonic Stem cell-derived Schwann cells; these are 
Neuregulin-induced “Schwann cells” derived from the mESC.  ESSC +4iPP: under 
these conditions, the differentiated “Schwann cell lawns on the Schwann cell side of the 
device were treated with the biochemical MIF inhibitor 4iPP (as described in Methods 
and in Shen et al., 2012).  ESSC+ α-MIF: Downstream MIF effects were blocked by 
addition of a function-blocking anti-MIF antibody (α-MIF) as we had done in previous 
studies (Bank et al., 2012).  
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Significance Calculations for these data 
Differences between treatment groups and statistical significance were analyzed 
using Mann-Whitney U tests performed in Matlab. There were statistically significant 
differences found amongst these treatment groups with p values as indicated below: 
DHA alone: (mESC vs ESSC, p =0.0023; ESSC+4iPP vs ESSC, p = 3.1080 x10-4; 
ESSC+ α-MIF vs ESSC, p = 5.4390 x10-4) 
CNTF alone: (mESC vs ESSC, p =1.5540 x10-4; ESSC+4iPP vs ESSC, p =7.7700 x10-
5; ESSC+ α-MIF vs ESSC, p = 7.7700 x10-5) 
NGF alone: (mESC vs ESSC, p =0.0050; ESSC+4iPP vs ESSC, p =0.0015; ESSC+ α-
MIF vs ESSC, p = 0.0052) 
MIF alone: (mESC vs ESSC, p =5.4390 x10-4; ESSC+4iPP vs ESSC, p = 7.7700 x10-5; 
ESSC+ α-MIF vs ESSC, p = 7.7700 x10-5) 
Figure 3. RTqPCR quantification of gene marker expression in the differentiated 
neuron-like cells (a). OCT4 expression in undifferentiated mES cells and neuron-like 
cells differentiated from mES cells. D3: Undifferentiated condition, statoacoustic 
ganglion: (SAG) spiral ganglion neuron culture (control). (b). Expression of proneural 
marker genes in neuron-like cells cells. Ngn1, NeuroD and Nfil expression is much 
higher in neuronally differentiated cells, but not detected in undifferentiated condition 
(D3ES). (c). Expression of mature neuronal marker genes: TrkB, TrkC, Prph in the 
neuron-like cells are upregulated in all the neuronal differentiated conditions and 
expression levels are much higher under conditions with DHA addition. F12: Neuronal 
basal media, C: CNTF differentiation condition, N: NGF differentiation condition, M: MIF 
differentiation condition, D: DHA differentiation condition, CD: CNTF+DHA differentiation 
condition, ND: NGF+DHA differentiation condition, MD: MIF+DHA differentiation 
condition. (d). Expression of auditory neuronal markers, GabaAR, VgluT1 and SP19 are 
highly upregulated in the neuronal differentiation conditions compared to 
undifferentiated conditions and F12 (basal) medium. VgluT1 expression is much higher 
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in the MIF+DHA condition than all the other differentiation conditions, which was to be 
expected, given that MIF is the inner ear’s first differentiation “neurotrophin” (Holmes et 
al., 2011; Bank et al. 2012; Shen et al., 2012). 
 
Figure 4. Observations of myelination onset as neuron-like cells and Schwann cell-like 
cells interact in the mid-section of the Microfluidic device Row II.  The cultures were 
stained for neurofilament Heavy 200 kDa (NF-H) (red), Myelin Basic Protein (blue) and 
VgluT1 (green).  F12=the basal medium, CNTF=ciliary neurotrophic factor;  NGF=nerve 
growth factor; MIF=macrophage migration inhibitory factor;  DHA=docosahexaenoic 
acid (b) Merged images of multi-labelled devices (c) Cartoon showing the location of 
Row II, which is also shown Fig. 1. 
 
Figure 5. Patch clamp studies performed on the neuron-like cells induced by MIF. a. 
Electrodes were filled with ionic fluorescent rhodamine dye and used to patch clamp the 
cell membrane of cells identified as having a neuronal morphology. b. Phase contrast 
image of a group of differentiated neuron-like cells; the cells that were identified as 
having a bipolar neuronal morphology were patch-clamped using a fire polished glass 
pipette electrode. MIF- and DHA-treated ES cells showed voltage dependent inward 
and outward current with long active response times, demonstrating voltage-dependent 
currents in a neuron-like bipolar cell. Voltage dependent changes were seen in 
response to step depolarization from a holding potential of –80 mV. Both transient 
inward currents and maintained outward currents were observed. The linear leak 
currents and most of the linear capacity currents were removed during data acquisition 
with a P/8 protocol (although a small residual capacity transient is visible immediately 
after the voltage steps). The ionic conditions were set so that ENa and EK were at 
normal levels and neither sodium nor potassium channels were blocked, so the 
responses to small voltage steps are dominated by transient inward sodium currents 
that got faster as the cell was depolarized, and the response to large steps was 
dominated by a maintained outward current.  
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Figure 6. Two types of cochlear implants coated with hydrogels with encapsulated 
Schwann cell-like cells: a. Platinum iridium eight array electrode of the type used in 
human patients. b. Platinum iridium electrode with a ball at the end of the type used in 
animal studies The differentiated Schwann cell-like cells were grown in layers on the 
electrodes in sodium alginate hydrogels for 2 weeks; Healthy Schwann cell-like cells are 
visible in 5-6 layers on both cochlear implants (a) and (b).  (c) Higher magnification 
phase contrast imge of the hydrogel layers on a ball implant.  (d) Fluorescence 
micrograph of the same cochlear impant pictured in (c). Live/Dead staining was used to 
distinguish living from dead cells.  Ethidium homodimer was used to stain dead cells- 
(orange) and calcein AM was used to stain the live cells (green).  The implant was 
coated with hydrogel-encapsulated Schwann cells, which were maintained for 2 weeks 
in the encapsulated form and then checked for viability. The scale bar in (d), the 
fluorescence image, applies to both (c) and (d). 
 
Figure 7. Neurites of embryonic mouse (Eday 12.5) statoacoustic ganglion interact with 
Schwann cell-like cells in the hydrogel layers on a ball type cochlear implant at 2 weeks 
in culture. At the beginning of the experiment the statoacoustic ganglion was placed 1 
cm away from the Schwann cell-like coated cochlear implant on a porcine gel coated 
tissue culture dish. Interactions with the cell coats on the impants were followed by time 
lapse digital cinematography over the entire 2 week period. The processes and some 
neuronal cell bodies reached the cochlear implant after 4-5 days. These photographs 
were taken at 13 days. (a) Neurites (and some cell bodies) were labelled by 
immunocytochemistry for Neurofilament 150kDa (Nfil) protein marker and a secondary 
antibody (AlexaFlor 580 (red) labels the extensive processes that had reached the 
cochlear implant. The blue crescent of labelling at the bottom represents the DAPI 
labelled Schwann cell-like cell nuclei.  (b) the phase contrast micrograph view of these 
processes/cells from the statoacoustic ganglion and the implant (same field as (a).  (c) 
DAPI-stained nuclei of the Schwann cell-like cells are seen in blue within the hydrogel 
“coats” in this micrograph of the "blue" channel.  No directional statoacoustic ganglion 
neurite outgrowth was seen when the statoacoustic ganglion explants were co-cultured 
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with a bare cochlear implant or with a cochlear implant coated with hydrogel layers 
containing undifferentiated stem cells. 
 
Figure 8. Interaction of primary spiral ganglion neurites (mouse post natal day 3 (a) and 
processes from MIF-induced neuron-like cell neurites (b) with wild type Organ of Corti 
explants in culture.  (a) Polarized image of a primary mouse spiral ganglion (right) 
extending extensive neurites directionally toward a wild type Organ of Corti explant (at 
left). No directional outgrwoth was seen towards a MIF knock out mouse Organ of Corti 
(not shown). This was also demonstrated in separate experiments detailed in Bank et 
al., 2012, (Fig. 6 in that paper). (b) MIF-induced neuron-like cells stained with acetylated 
tubulin (green) cultured with a wild type Organ of Corti explant for a week showed 
fasciculated neurites (approaching form the right) growing towards the wild-type Organ 
of Corti (at lower left) No such outgrowth was seen towards OC explants from MIF-KO 
mice (as was also demonstrated for primary spiral ganglion neuronal processes in Bank 
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OCT4   
Early stage neuronal 
markers 
Neurogenin1(Ngn1) GAGCCGGCTGACAATACAAT AAAGTACCCTCCAGTCCAG 
NeuroD AGGCTCCAGGGTTATGAGAT TGTTCCTCGTCCTGAGAACT 









receptor type 3 (Trkc) 
AACCATCACGAGAAAGCCTG ACCATCTCCACCTCTGCTTA 








transporter 1 (VgluT1) 
CCAAGCTCATGAACCCTGTT ACCTTGCTGATCTCAAAGCC 
Voltage gated sodium 





Table 1 Primer Pairs for Assessing General and Inner Ear Specific Neuronal 
Differentiation 
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